Clinical Trial Update: Impact of HCV Treatment on Neurocognitive Functions and Brain Metabolism [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the impact of hepatitis C treatment on neurocognitive function and brain metabolism has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Kirby Institute | Conditions: Hepatitis C, Chronic | Phase 4 | Status: WITHDRAWN